Science Explorer Interactive view Map
Company · London · United Kingdom

CTI BioPharma (United Kingdom)

ctibiopharma.comROR OpenAlex
Research works
108
▲ 99% vs 2013–17
Citations
4.9k
45.0 per fractional work
Top-10% rate
20.0%
record average 16.5%
Open access
28%
world 28%

Not ranked overall: CTI BioPharma (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.13× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 5.32× its world share, 1 worksImmunology and Micro…Neuroscience: 1.10× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.69× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.09× its world share, 0 worksComputer ScienceEngineering: 0.21× its world share, 0 worksEngineeringMaterials Science: 0.26× its world share, 0 worksMaterials ScienceHealth Professions: 0.51× its world share, 0 worksHealth ProfessionsMedicine: 2.16× its world share, 5 worksMedicineNursing: 2.74× its world share, 0 worksNursingEconomics, Econometrics and Finance: 4.82× its world share, 1 worksEconomics, Econometr…Psychology: 0.22× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.1×. Every wedge is a field page.

Which keywords describe research at CTI BioPharma (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Immunotherapy, Cancer, Tumor Microenvironment, Gene Therapy, Glycosylation, Tumor Regression and Mass Spectrometry.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation11▲ 4.2×27 topics
  2. Cancer8▲ 5.5×18 topics
  3. Immunotherapy7▲ 10×12 topics
  4. Tumor Microenvironment7▲ 18×7 topics
  5. Gene Therapy6▲ 21×3 topics
  6. Glycosylation6▲ 23×3 topics
  7. Tumor Regression6▲ 58×2 topics
  8. Mass Spectrometry5▲ 24×4 topics
  9. Monoclonal Antibodies5▲ 33×3 topics
  10. Therapeutic Antibodies5▲ 33×2 topics
  11. Immune Response4▲ 6.8×7 topics
  12. Angiogenesis4▲ 9.8×7 topics
  13. Proteomics4▲ 34×2 topics
  14. Cancer Therapy4▲ 5.6×11 topics
  15. Metastasis4▲ 10×7 topics
  16. Tumor Targeting4▲ 27×3 topics
  17. Chemotherapy4▲ 4.6×13 topics
  18. Arginine Deprivation3▲ 70×1 topic
  19. Bacterial Therapy3▲ 70×1 topic
  20. IL-63▲ 94×1 topic
  21. STAT33▲ 94×1 topic
  22. Antibody Engineering3▲ 29×1 topic
  23. Cancer Immunotherapy3▲ 21×3 topics
  24. Drug Discovery3▲ 7.2×4 topics
  25. Fc Receptors3▲ 29×1 topic
  26. Autoimmunity3▲ 14×4 topics
  27. Cell Signaling3▲ 7.8×4 topics
  28. Lymphoma3▲ 17×3 topics
  29. Biopharmaceuticals3▲ 35×3 topics
  30. Cancer Progression2▲ 10×4 topics
  31. Electrospray2▲ 30×1 topic
  32. Innate Immunity2▲ 6.8×8 topics
  33. Ionization2▲ 30×1 topic
  34. Stromal Cells2▲ 25×2 topics
  35. PET Imaging2▲ 10×4 topics
  36. Cost-effectiveness Analysis2▲ 28×1 topic
  37. Health Utility Measures2▲ 28×1 topic
  38. Leukemia2▲ 33×2 topics
  39. CAR T Cells2▲ 47×1 topic
  40. TGF-ß2▲ 12×2 topics

Which research topics does CTI BioPharma (United Kingdom) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Protease and Inhibitor Mechanisms, CAR-T cell therapy research and Connective tissue disorders research.

Health Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksProtease and Inhibitor Mechanisms: 1 fractional worksCAR-T cell therapy research: 0 fractional worksConnective tissue disorders research: 0 fractional worksPlatelet Disorders and Treatments: 0 fractional worksHemostasis and retained surgical items: 0 fractional worksCRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional worksTrauma, Hemostasis, Coagulopathy, Resuscitation: 0 fractional worksBone fractures and treatments: 0 fractional works3D Printing in Biomedical Research: 0 fractional works
Economics and EconometricsCancer ResearchOncologyGenetics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  2. 2 Protease and Inhibitor Mechanisms Cancer Research 1 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Connective tissue disorders research Genetics 0 works
  5. 5 Platelet Disorders and Treatments Hematology 0 works
  6. 6 Hemostasis and retained surgical items Hematology 0 works
  7. 7 CRISPR and Genetic Engineering Molecular Biology 0 works
  8. 8 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works
  9. 9 Bone fractures and treatments Epidemiology 0 works
  10. 10 3D Printing in Biomedical Research Biomedical Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.5%not open71.5%

World: 28% of research is openly available.

with international co-authors42.3%domestic only57.7%

World: 19% is written across borders.

How has CTI BioPharma (United Kingdom)'s research output changed?

Output in 2018–2022 was 99% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.